BioCentury
ARTICLE | Financial News

AlgoRx amends IPO

February 10, 2005 8:00 AM UTC

Pain therapeutics company AlgoRx (Secaucus, N.J.) lowered the proposed price range of its IPO and now hopes to sell 6.8 million shares at $7-$8 instead of the previous range of $10-$12. If sold at $7....